Stanford Department of Medicine would like to invite all Stanford community members to attend this instance of the Medicine Grand Rounds (MGR) series, which will feature Katherine A. High, MD, a gene therapy pioneer who co-founded Spark Therapeutics, won the 2026 Breakthrough Prize in Life Sciences, and led the team that won FDA approval for Luxturna, the first gene therapy for an inherited disease.

CE accreditation info here.

CME Activity ID: 58642

MOC Credit (1): Complete this form after each session; reflective statement (1-2 sentences) required.